Found: 27
Select item for more details and to access through your institution.
Interactions between GSK3β and caspase signalling pathways during NGF deprivation induced cell death.
- Published in:
- Journal of Alzheimer's Disease, 2002, v. 4, n. 4, p. 291, doi. 10.3233/JAD-2002-4404
- By:
- Publication type:
- Article
NGF increases neuritic complexity of cholinergic interneurons in organotypic cultures of neonatal rat striatum.
- Published in:
- Journal of Comparative Neurology, 1994, v. 340, n. 2, p. 281, doi. 10.1002/cne.903400212
- By:
- Publication type:
- Article
Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 1, p. 144, doi. 10.1002/alz.12000
- By:
- Publication type:
- Article
O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [<sup>18</sup> F]PI‐2620 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1268, doi. 10.1016/j.jalz.2019.06.4810
- By:
- Publication type:
- Article
IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [<sup>18</sup> F]PI‐2620 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P45, doi. 10.1016/j.jalz.2019.06.4202
- By:
- Publication type:
- Article
P4‐389: ELENBECESTAT, E2609, A BACE INHIBITOR: RESULTS FROM A PHASE‐2 STUDY IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT AND MILD‐TO‐MODERATE DEMENTIA DUE TO ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1623, doi. 10.1016/j.jalz.2018.07.213
- By:
- Publication type:
- Article
DT‐01‐07: TREATMENT OF EARLY AD SUBJECTS WITH BAN2401, AN ANTI‐Aβ PROTOFIBRIL MONOCLONAL ANTIBODY, SIGNIFICANTLY CLEARS AMYLOID PLAQUE AND REDUCES CLINICAL DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1668, doi. 10.1016/j.jalz.2018.07.009
- By:
- Publication type:
- Article
P4‐291: BASELINE FLORBETAPIR AMYLOID PET STANDARD UPTAKE VALUE RATIO (SUVR) CAN PREDICT CLINICAL PROGRESSION IN PRODROMAL AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1560, doi. 10.1016/j.jalz.2018.07.113
- By:
- Publication type:
- Article
P4‐075: LUMIPULSE<sup>®</sup> G TOTAL TAU TO β‐AMYLOID 1‐42 RATIO CUT‐POINT DETERMINATION FOR AMYLOID ELIGIBILITY SCREENING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1463, doi. 10.1016/j.jalz.2018.06.2478
- By:
- Publication type:
- Article
P1‐055: E2027, A NOVEL PHOSPHODIESTERASE‐9 (PDE9) INHIBITOR IN DEVELOPMENT FOR TREATMENT OF DEMENTIA WITH LEWY BODIES (DLB), SHOWED NO CLINICALLY SIGNIFICANT DRUG INTERACTION WITH DILTIAZEM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P289, doi. 10.1016/j.jalz.2018.06.057
- By:
- Publication type:
- Article
P1‐040: ELENBECESTAT, A NOVEL BACE INHIBITOR, DEMONSTRATES SIMILAR PHARMACOKINETICS AND TOLERABILITY IN JAPANESE SUBJECTS WITH MULTIPLE DOSINGS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P282, doi. 10.1016/j.jalz.2018.06.041
- By:
- Publication type:
- Article
O1‐12‐06: PHASE 1 MULTIPLE ASCENDING DOSE (MAD) STUDY OF PHOSPHODIESTERASE‐9 INHIBITOR E2027: CONFIRMATION OF TARGET ENGAGEMENT AND SELECTION OF PHASE 2 DOSE IN DEMENTIA WITH LEWY BODIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P251, doi. 10.1016/j.jalz.2018.06.2401
- By:
- Publication type:
- Article
POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P258, doi. 10.1016/j.jalz.2017.06.123
- By:
- Publication type:
- Article
PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P574, doi. 10.1016/j.jalz.2017.07.194
- By:
- Publication type:
- Article
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, n. 1, p. 45, doi. 10.1016/j.jalz.2016.09.014
- By:
- Publication type:
- Article
The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer’s disease: For the coalition against major diseases.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P296, doi. 10.1016/j.jalz.2015.07.406
- By:
- Publication type:
- Article
A case-control cohort study to define a threshold for the tau/abeta42 ratio in cerebrospinal fluid optimized for diagnosis of Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P873, doi. 10.1016/j.jalz.2015.08.071
- By:
- Publication type:
- Article
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 840, doi. 10.1016/j.jalz.2015.04.001
- By:
- Publication type:
- Article
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 6, p. e1, doi. 10.1016/j.jalz.2014.11.001
- By:
- Publication type:
- Article
Gingival and mucosal reactions after intensive chlorhexidine gel treatment with or without oral hygiene measures.
- Published in:
- European Journal of Oral Sciences, 1988, v. 96, n. 6, p. 557, doi. 10.1111/j.1600-0722.1988.tb01596.x
- By:
- Publication type:
- Article
Immunohistochemical study of neuronal markers in human gingiva with phenytoin-induced overgrowth.
- Published in:
- European Journal of Oral Sciences, 1988, v. 96, n. 4, p. 339, doi. 10.1111/j.1600-0722.1988.tb01565.x
- By:
- Publication type:
- Article
Effects of 1% chlorhexidine gel treatment on sympathetic adrenergic nerves in human buccal mucosa.
- Published in:
- European Journal of Oral Sciences, 1986, v. 94, n. 1, p. 47, doi. 10.1111/j.1600-0722.1986.tb01362.x
- By:
- Publication type:
- Article
Trimethyltin-induced expression of GABA and vimentin immunoreactivities in astrocytes of the rat brain.
- Published in:
- Glia, 1994, v. 11, n. 4, p. 378, doi. 10.1002/glia.440110410
- By:
- Publication type:
- Article
Modelling of amyloid β-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats.
- Published in:
- Experimental Brain Research, 2006, v. 168, n. 1/2, p. 11, doi. 10.1007/s00221-005-0069-z
- By:
- Publication type:
- Article
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation.
- Published in:
- Nature Neuroscience, 2001, v. 4, n. 9, p. 887, doi. 10.1038/nn0901-887
- By:
- Publication type:
- Article
Plant-Derived Neurotoxic Amino Acids ( β-N-Oxalylamino-l-Alanine and β-N-Methylamino-l-Alanine): Effects on Central Monoamine Neurons.
- Published in:
- Journal of Neurochemistry, 1990, v. 55, n. 3, p. 941, doi. 10.1111/j.1471-4159.1990.tb04582.x
- By:
- Publication type:
- Article
Immunohistological study of neuronal markers in inflamed gingiva obtained from children with Down's syndrome.
- Published in:
- 1991
- By:
- Publication type:
- Abstract